New insights into cellular mechanisms during sepsis

Immunologic Research

Volumn 34, Issue 2, 2006, Pages 133-141

  Hoesel, Laszlo M ^a   Gao, Hongwei ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cardiomyocytes; Complement system; Multiorgan failure; Neutrophils; Sepsis

Indexed keywords

CAUSE OF DEATH; CELLULAR IMMUNITY; CLINICAL RESEARCH; COMPLEMENT SYSTEM; CONTROLLED STUDY; DETERIORATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOREGULATION; LIVER CELL; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; HEART; HUMANS; MYOCYTES, CARDIAC; NEUTROPHILS; RECEPTOR, ANAPHYLATOXIN C5A; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33745683792     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:34:2:133     Document Type: Review

References (51)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348(16):1546-1554.
2. Muckart DJ, Bhagwanjee S: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997;25(11):1789-1795.
3. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24(7):1125-1128.
4. Riedemann NC, Guo RF, Bernacki KD, et al: Regulation by C5a of neutrophil activation during sepsis. Immunity 2003;19(2):193-202.
5. Hebert PC, Drummond AJ, Singer J, Bernard GR, Russell JA: A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993;104(1):230-235.
6. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23(10):1638-1652.
7. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286(14):1754-1758.
8. Goya T, Morisaki T, Torisu M: Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function. Surgery 1994;115(2):145-155.
9. Welbourn CR, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB: Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 1991;78(6):651-655.
10. Windsor AC, Mullen PG, Fowler AA, Sugerman HJ: Role of the neutrophil in adult respiratory distress syndrome. Br J Surg 1993;80(1):10-17.
11. Huber-Lang M, Sarma VJ, Lu KT, et al: Role of C5a in multiorgan failure during sepsis. J Immunol 2001;166(2):1193-1199.
12. Czermak BJ, Sarma V, Pierson CL, et al: Protective effects of C5a blockade in sepsis. Nat Med 1999;5(7):788-792.
13. Huber-Lang MS, Younkin EM, Sarma JV, et al: Complement-induced impairment of innate immunity during sepsis. J Immunol 2002;169(6):3223-3231.
14. Cain SA, Monk PN: The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J Biol Chem 2002;277(9):7165-7169.
15. Verdrengh M, Tarkowski A: Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997;65(7):2517-2521.
16. Czuprynski CJ, Theisen C, Brown JF: Treatment with the antigranulocyte monoclonal antibody RB6-8C5 impairs resistance of mice to gastrointestinal infection with Listeria monocytogenes. Infect Immun 1996;64(9):3946-3949.
17. Han Y, Cutler JE: Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J Infect Dis 1997;175(5):1169-1175.
18. Sisley AC, Desai T, Harig JM, Gewertz BL: Neutrophil depletion attenuates human intestinal reperfusion injury. J Surg Res 1994;57(1):192-196.
19. Dovi JV, He LK, DiPietro LA: Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003;73(4):448-455.
20. Hewett JA, Schultze AE, VanCise S, Roth RA: Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest 1992;66(3):347-361.
21. Molnar RG, Wang P, Ayala A, Ganey PE, Roth RA, Chaudry IH: The role of neutrophils in producing hepatocellular dysfunction during the hyperdynamic stage of sepsis in rats. J Surg Res 1997;73(2):117-122.
22. Sato T, Shinzawa H, Abe Y, Takahashi T, Arai S, Sendo F: Inhibition of Corynebacterium parvum-primed and lipopolysaccharide-induced hepatic necrosis in rats by selective depletion of neutrophils using a monoclonal antibody. J Leukoc Biol 1993;53(2):144-150.
23. Heinzelmann M, Mercer-Jones MA, Passmore JC: Neutrophils and renal failure. Am J Kidney Dis 1999;34(2):384-399.
24. Hoesel LM, Neff TA, Neff SB, et al: Harmful and protective roles of neutrophils in sepsis. Shock 2005;24(1):40-47.
25. Haslett C: Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci (Lond) 1992;83(6):639-648.
26. Jimenez MF, Watson RW, Parodo J, et al: Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 1997;132(12):1263-1269; discussion 1269-1270.
27. Gerard NP, Hodges MK, Drazen JM, Weller PF, Gerard C: Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem 1989;264(3):1760-1766.
28. Gerard NP, Gerard C: The chemotactic receptor for human C5a anaphylatoxin. Nature 1991;349(6310):614-617.
29. Chenoweth DE, Hugli TE: Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 1978;75(8):3943-3947.
30. Kurimoto Y, de Weck AL, Dahinden CA: Interleukin 3-dependent mediator release in basophils triggered by C5a. J Exp Med 1989;170(2):467-479.
31. Werfel T, Oppermann M, Schulze M, Krieger G, Weber M, Gotze O: Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood 1992:79(1):152-160.
32. Riedemann NC, Guo RF, Neff TA, et al: Increased C5a receptor expression in sepsis. J Clin Invest 2002;110(1):101-108.
33. Haviland DL, McCoy RL, Whitehead WT, et al: Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 1995;154(4):1861-1869.
34. Zahedi R, Braun M, Wetsel RA, et al: The C5a receptor is expressed by human renal proximal tubular epithelial cells. Clin Exp Immunol 2000;121(2):226-233.
35. Koleva M, Schlaf G, Landmann R, Gotze O, Jungermann K, Schieferdecker HL: Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from Kupffer cells. Gastroenterology 2002;122(3):697-708.
36. Schieferdecker HL, Schlaf G, Jungermann K, Gotze O: Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. Int Immunopharmacol 2001;1(3):469-481.
37. Paine R, 3rd, Rolfe MW, Standiford TJ, Burdick MD, Rollins BJ, Strieter RM: MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J Immunol 1993;150(10):4561-4570.
38. Riedemann NC, Guo RF, Sarma VJ, et al: Expression and function of the C5a receptor in rat alveolar epithelial cells. J Immunol 2002;168(4):1919-1925.
39. Krishnagopalan S, Kumar A, Parrillo JE: Myocardial dysfunction in the patient with sepsis. CUIT Opin Crit Care 2002;8(5):376-388.
40. Levy RJ, Deutschman CS: Evaluating myocardial depression in sepsis. Shock 2004;22(1):1-10.
41. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W: A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985;76(4):1539-1553.
42. Meng X, Ao L, Meldrum DR, et al: TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol 1998;275(2 Pt 2):R502-508.
43. Niederbichler AD, Hoesel LM, Westfall MV, et al: An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J Exp Med 2006;203(1):53-61.
44. Yang S, Chung CS, Ayala A, Chaudry IH, Wang P: Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock 2002;17(1):55-60.
45. Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth 2001;15(3):364-376.
46. Nakae H, Endo S, Inada K, Takakuwa T, Kasai T, Yoshida M: Serum complement levels and severity of sepsis. Res Commun Chem Pathol Pharmacol 1994;84(2):189-195.
47. Bengtson A, Heideman M: Anaphylatoxin formation in sepsis. Arch Surg 1988;123(5):645-649.
48. deBoer JP, Creasey AA, Chang A, et al: Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern. Infect Immun 1993;61(10):4293-4301.
49. Smedegard G, Cui LX, Hugli TE: Endotoxin-induced shock in the rat. A role for C5a. Am J Pathol 1989;135(3):489-497.
50. Riedemann NC, Guo RF, Hollmann TJ, et al: Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 2004;18(2):370-372.
51. Guo RF, Riedemann NC, Bernacki KD, et al: Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J 2003;17(13):1889-1891.